X4 Pharmaceuticals, Inc
CIK
1501697
Latest Filing
Aug 18, 2025, 04:26 PM
13D Filings
Filer | Latest Filing | % Owned | Type | Filed | |
|---|---|---|---|---|---|
Growth Equity Opportunities 18 VGE, LLC | 0001072613-25-000747 | 6.20% ▼ -3.79% | Amendment | Oct 29, 2025, 06:04 PM | |
Coastlands Capital LP | 0001104659-25-079821 | 9.99% | NEW | Aug 18, 2025, 04:26 PM | |
Growth Equity Opportunities 18 VGE, LLC | 0001072613-25-000643 | 9.99% | Amendment | Aug 15, 2025, 04:54 PM | |
Bain Capital Life Sciences Fund, L.P. | 0000950170-25-108341 | 9.99% | NEW | Aug 13, 2025, 09:40 PM | |
Rows:
20
1–4 of 4
1